The FDA Is Broken
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients. More
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients. More
“This drug needs to be pulled off the market — period," said Adam Uratro, the chief of maternal-fetal medicine at MetroWest Medical Center. More
As a matter of simple economics, hospital price transparency will improve competition and encourage more equitable pricing. More
og:description Medical journals are relied on as trusted sources of medical information. For years, authors’ conflicts of interest—both disclosed and undisclosed— have repeatedly undermined the credibility of the medical profession and the medical literature. More
Health care groups don't want transparency that reveals true prices. More
Congress tapped a national academies committee to examine a drug cost issue. It got a report that includes “egregious” failures to disclose conflicts of interest. More
Although we examined only one common shoppable service in this post, the importance of identifying high-price hospitals is generalizable to a broad range of hospital services. More
Medicare Advantage is fundamentally altering Medicare's structure. More
Aggressive sales tactics have allegedly led surgeons to use defective or wrong-size implants, screws or other products on patients, including former Olympian Mary Lou Retton. More
Inspectors repeatedly found manufacturing and device quality problems with the HeartWare heart pump. But the FDA did not penalize the company, and patients had the device implanted on their hearts without knowing the facts. More